Reports - Venture Capital Activity Declines 29% Following the Holiday Weekend

Share Article identified that $260 million was raised primarily by California based biotechnology companies. In addition, two companies began trading on Wall Street this reporting period. identified that $260 million of venture capital was invested in 21 U.S.-based companies during this week’s reporting period. The average deal size was approximately $12.38 million. The amount of venture capital invested this period decreased by 29% over last week’s $363 million. For a full graphical analysis go to

The two IPO’s this reporting period are: Global Signal, Inc. and Inhibitex, Inc.

Venture Capital Investments by Region

Geographically, 10 California companies raised $167.3 million in venture financings. The largest venture financing in California this period went into ARYx Therapeutics, Inc. for $55 million. ARYx Therapeutics, Inc. is a Santa Clara based company that develops new pharmaceuticals based on its retrometabolic design platform to engineer safer drugs within multiple therapeutic areas.

Venture Capital Investments by Sector

The biotechnology sector raised 33% of the venture capital this period. 4 biotechnology companies raised over $86 million in venture financing. The largest venture financing was by ARYx Therapeutics, Inc.

Venture Capital Investments by Round

Companies raising their later stage rounds led this week’s venture capital activity. Later stage companies represented 53% of the total venture capital deployed this period. The largest later stage financing went into ARYx Therapeutics, Inc.

Top Three Venture Capital Investments

The three largest venture deals this period are as follows:

1.    ARYx Therapeutics

2.    Pay By Touch

3.    AmberWave Systems

Venture Capitalists funding the Top Three Deals

The following seventeen investors funded the above mentioned top three venture capital investments for a total of $101 million: 3i Group, Adams Capital, ARCH Venture Partners, ATEL Ventures, Gordon P Getty Family Trust, Itochu Corp, JAFCO America Ventures, Merlin BioMed Group, Mobius Venture Capital, Montreux Equity Partners, MPM Capital L.P., Nomura Phase4 Ventures, Novel Bioventures, OrbiMed Advisors, Scottish Widows Investment Partnership, TeleSoft Ventures, and The Hillman Company.

A total of 36 equity financings of private and public companies occurred during this reporting period. Each of the 36 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.

About is a financial information service company that collects and disseminates data on investors and their corresponding equity financings. Also available is access to over 30,000 other historic equity financings through the searchable database.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dante Fichera CPA
Visit website